Toggle navigation
Home
Search
Services
Blog
Contact
About
Expression Pattern Screening for Drug Discovery
Martel, Ralph R.
High Throughput Genomics, Inc., Tucson, AZ, United States
Search 3 grants from Ralph Martel
Search grants from High Throughput Genomics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Characterization of Coagulation Factor-platelet Interactions: Role of FXI
Does Runx1 Suppress Breast Cancer Stemness by mediating higher order chromatin organization?
2/2 Kisspeptin Regulation and GPR54 Signaling in Reproduction
Dietary &Physical Activity Patterns of Latino Farmworker Children
Drug Abuse Treatment Outcome Study
Recently added grants:
Chemokines in healing myocardial infarction
Molecular and Cellular Control of Angiogenesis
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
Omics Phenotyping for Identifying Molecular Signatures of the Healthy and Failing Heart: An Integrated Data Science Platform
TAM-Kinases in Transplant
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA084874-03
Application #
6514349
Study Section
Special Emphasis Panel (ZRG1-SSS-2 (10))
Program Officer
Forry, Suzanne L
Project Start
2001-03-27
Project End
2004-02-29
Budget Start
2002-03-01
Budget End
2004-02-29
Support Year
3
Fiscal Year
2002
Total Cost
$528,553
Indirect Cost
Institution
Name
High Throughput Genomics, Inc.
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85706
Related projects
NIH 2002
R44 CA
Expression Pattern Screening for Drug Discovery
Martel, Ralph R. / High Throughput Genomics, Inc.
$528,553
NIH 2001
R44 CA
Expression Pattern Screening for Drug Discovery
Martel, Ralph R. / Siddco, Inc.
$551,315
Comments
Be the first to comment on Ralph Martel's grant